CLOS
NVAX icon

Compagnie Lombard Odier SCmA’s Novavax NVAX Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-850
Closed -$10.8K – 471
2024
Q2 		$10.8K Sell
850
-1,750
-67% -$17.6K ﹤0.01% 393
2024
Q1 		$12.4K Sell
2,600
-988
-28% -$4.58K ﹤0.01% 417
2023
Q4 		$17.2K Hold
3,588
– – ﹤0.01% 469
2023
Q3 		$26K Sell
3,588
-1,998
-36% -$16K ﹤0.01% 474
2023
Q2 		$41.5K Hold
5,586
– – ﹤0.01% 425
2023
Q1 		$38.7K Hold
5,586
– – ﹤0.01% 468
2022
Q4 		$56K Buy
5,586
+2,886
+107% +$50.9K ﹤0.01% 462
2022
Q3 		$49K Hold
2,700
– – ﹤0.01% 461
2022
Q2 		$138K Hold
2,700
– – ﹤0.01% 343
2022
Q1 		$198K Buy
2,700
+920
+52% +$82K ﹤0.01% 309
2021
Q4 		$255K Buy
1,780
+600
+51% +$103K 0.01% 325
2021
Q3 		$245K Buy
1,180
+130
+12% +$28.7K 0.01% 328
2021
Q2 		$223K Sell
1,050
-65,852
-98% -$12.1M ﹤0.01% 332
2021
Q1 		$12.1M Buy
+66,902
New +$13.3M 0.27% 76
2020
Q4 		– Sell
-600
Closed -$65K – 600
2020
Q3 		$65K Buy
+600
New +$73.1K ﹤0.01% 372
2016
Q3 		– Sell
-700
Closed -$102K – 920
2016
Q2 		$102K Buy
+700
New +$80.2K ﹤0.01% 562

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Compagnie Lombard Odier SCmA's NVAX Position: Q3 2024 in Review

Compagnie Lombard Odier SCmA sold out of Novavax (NVAX) in Q3 2024, closing a stake of 850 shares — an estimated $10.8K sold.

Compagnie Lombard Odier SCmA first reported a position in NVAX in Q2 2016 and held it in 16 quarters. The position peaked at $12.1M in Q1 2021. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • Compagnie Lombard Odier SCmA reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 850 Novavax shares in Q3 2024, an estimated $10.8K.
  • Compagnie Lombard Odier SCmA first reported a position in Novavax in Q2 2016 and held it in 16 quarters.
  • Compagnie Lombard Odier SCmA's Novavax position peaked at $12.1M in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2024, filed 11 Oct 2024.